Brief topical application of TRPV3 channel agonist carvacrol mediates skin vasodilation via NOS, COX, and K+ channel pathways in young adults
European Journal of Pharmacology · 2025
DOI: 10.1016/j.ejphar.2025.178347 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Pharmacology, 2025. Verfasst von Naoto Fujii und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Health and Sport Sciences, University of Tsukuba, Tsukuba, Japan; Advanced Research Initiative for Human High Performance (ARIHHP), Univ…. Hauptthemen laut MEDLINE: Vasodilation, Skin, TRPV Cation Channels, Nitric Oxide Synthase. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Government of Japan Ministry of Education Culture Sports Science and Technology.
Abstract (Originalsprache)
We investigated the influence of a brief, 1-min topical application of carvacrol, a transient receptor potential vanilloid 3 (TRPV3) channel activator, on cutaneous vasodilation and the mechanism(s) governing this response. In experiment 1 (n = 10), cutaneous vascular conductance (CVC) was measured for 90 min at four forearm sites treated with: 1) lactated Ringer's serving as a control, 2) 20 mM L-NAME, a nitric oxide synthase (NOS) inhibitor, 3) 10 mM ketorolac, a cyclooxygenase (COX) inhibitor, or 4) both inhibitors combined. In experiment 2 (n = 10), CVC was assessed at four forearm sites for 90 min treated with: 1) lactated Ringer's, 2) 50 mM tetraethylammonium, a Ca2+-activated K+ (KCa) channel blocker, 3) 10 mM 4-Aminopyridine, a voltage-gated K+ (Kv) channel blocker, and 4) 50 mM BaCl2, a non-selective K+ channel blocker. 10 % carvacrol was topically applied for 1 min at all sites using a cotton swab, with inhibitors/blockers administered intradermally via microdialysis. At the control site, carvacrol elevated CVC to ∼40 %max, a response that persisted throughout 90 min. This increase was attenuated by separate and combined inhibition of NOS and COX (≥30 min), as well as by KCa channel blockade (20-50 min) and non-selective K+ channel blockade (from 20 min onward). Kv blockade augmented carvacrol-induced increases in CVC during early stage (10-20 min). We showed that a brief, 1-min topical activation of TRPV3 channels with 10 % carvacrol induced a moderate and prolonged cutaneous vasodilation in young adults, mediated through NOS-, COX-, and K+-channel dependent pathways.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Health and Sport Sciences, University of Tsukuba, Tsukuba, Japan; Advanced Research Initiative for Human High Performance (ARIHHP), University of Tsukuba, Tsukuba, Japan. Electronic address: fujii.naoto.gb@…
- Institute of Health and Sport Sciences, University of Tsukuba, Tsukuba, Japan. Electronic address: 0731masanobu@gmail.com.
- Human and Environmental Physiology Research Unit, University of Ottawa, Ottawa, Canada. Electronic address: gkenny@uottawa.ca.
- Laboratory for Exercise and Environmental Physiology, Faculty of Education, Niigata University, Niigata, Japan. Electronic address: amano@ed.niigata-u.ac.jp.
- College of Physical Education, Hubei Normal University, Huangshi, China. Electronic address: 1755195376@qq.com.
- Institute of Health and Sport Sciences, University of Tsukuba, Tsukuba, Japan. Electronic address: watanabe.koichi.ga@u.tsukuba.ac.jp.
Förderung
- Government of Japan Ministry of Education Culture Sports Science and Technology
Zitieren
APA
Fujii, N., Kajiki, M., Kenny, G. P., Amano, T., Lei, T. H., Watanabe, K., & Nishiyasu, T. (2025). Brief topical application of TRPV3 channel agonist carvacrol mediates skin vasodilation via NOS, COX, and K+ channel pathways in young adults. European Journal of Pharmacology. https://doi.org/10.1016/j.ejphar.2025.178347
Vancouver
Fujii N, Kajiki M, Kenny GP, Amano T, Lei TH, Watanabe K, et al. Brief topical application of TRPV3 channel agonist carvacrol mediates skin vasodilation via NOS, COX, and K+ channel pathways in young adults. European Journal of Pharmacology. 2025. doi:10.1016/j.ejphar.2025.178347
BibTeX
@article{Fujii2025,
author = {Fujii, Naoto and Kajiki, Masanobu and Kenny, Glen P and Amano, Tatsuro and Lei, Tze-Huan and Watanabe, Koichi and Nishiyasu, Takeshi},
title = {Brief topical application of TRPV3 channel agonist carvacrol mediates skin vasodilation via NOS, COX, and K+ channel pathways in young adults},
journal = {European Journal of Pharmacology},
year = {2025},
doi = {10.1016/j.ejphar.2025.178347}
}
EUVIMED